2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722.
about
ET(B) receptor-deficient rats exhibit reduced contraction to ET-1 despite an increase in ET(A) receptorsEndothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease.Contrasting effects of intervention with ETA and ETB receptor antagonists in hypertension induced by angiotensin II and high-salt dietEffect of ABT-627 (A-147627), a potent selective ET(A) receptor antagonist, on the cardiopulmonary profile of newborn lambs with surgically-induced diaphragmatic hernia.ETA activation mediates angiotensin II-induced infiltration of renal cortical T cells.Endothelin-1 as a master regulator of whole-body Na+ homeostasis.Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism.Endothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen speciesSystemic hypertension induced by hepatic overexpression of human preproendothelin-1 in rats.ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin.Role of ET-1 receptor binding and [Ca(2+)](i) in contraction of coronary arteries from DOCA-salt hypertensive rats.RhoA-Rho kinase mediates synergistic ET-1 and phenylephrine contraction of rat corpus cavernosum.X-ray structures of endothelin ETB receptor bound to clinical antagonist bosentan and its analog.ET receptor activation contributes to T cell accumulation in the kidney following ischemia-reperfusion injury
P2860
Q28582070-26BE40FD-7879-4B02-A30C-298663630196Q30488861-740205EC-D503-45A1-8A36-2D8AF2967724Q34630324-BAAC22FE-11A8-451E-99C7-A6A95E935A3CQ35043673-082B24C9-D3C1-4636-BACC-586F5ACFBB48Q35647856-34A90CED-2E77-4B2F-AB45-4158CFD35160Q36299879-170E221A-4AAA-4AA1-B4E0-DEAAEFA568F6Q36965292-C6BCA38A-01BA-4770-A3A3-9A58CAADA80EQ37084544-43DB9875-3982-447D-AE44-95810AAECF7BQ37361568-2A8F3F3E-69C1-4719-B403-2150C7F4A9C6Q43054826-F4010C82-DA61-46C1-8B57-0F00E87CCD3AQ43963458-983E0C4B-DC08-4E6A-BA79-1F961602234FQ44534215-91182493-F7ED-4D8F-93E9-BBE1CE86CD75Q47929318-E8F6ECC9-1D90-473F-8472-E7EDD016BD13Q58756809-AFFC8F83-4C8E-454A-ADF7-9EE5C36B739D
P2860
2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
2,4-Diarylpyrrolidine-3-carbox ...... sts. 1. Discovery of A-127722.
@en
2,4-Diarylpyrrolidine-3-carbox ...... sts. 1. Discovery of A-127722.
@nl
type
label
2,4-Diarylpyrrolidine-3-carbox ...... sts. 1. Discovery of A-127722.
@en
2,4-Diarylpyrrolidine-3-carbox ...... sts. 1. Discovery of A-127722.
@nl
prefLabel
2,4-Diarylpyrrolidine-3-carbox ...... sts. 1. Discovery of A-127722.
@en
2,4-Diarylpyrrolidine-3-carbox ...... sts. 1. Discovery of A-127722.
@nl
P2093
P356
P1476
2,4-Diarylpyrrolidine-3-carbox ...... sts. 1. Discovery of A-127722.
@en
P2093
Hernandez L
Novosad EI
P304
P356
10.1021/JM9505369
P407
P577
1996-03-01T00:00:00Z